1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Rubis
  6. News
  7. MarketScreener Strategies
    RUI   FR0013269123

RUBIS

(RUI)
  Report
Real-time Euronext Paris  -  05/20 11:35:01 am EDT
26.33 EUR   +1.86%
05/10RUBIS : Release of the preparatory documents to the 9 June 2022 Combined Shareholders' Meeting
EQ
05/05RUBIS : Q1 2022 trading update – Excellent volume (+10% yoy) and gross profit (+7% yoy) development
PU
05/05RUBIS : Q1 2022 trading update ? Excellent volume (+10% yoy) and gross profit (+7% yoy) development
EQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Rubis : A technical turn-around configuration

01/06/2022 | 05:55am EDT
long trade on a pullback
Conditional Order Terminated
Entry price : 27.2€ | Target : 29.8€ | Stop-loss : 25.9€ | Cancellation Level : 29€ | Potential : 9.56%
Shares in Rubis reflect an interesting technical chart pattern allowing for a bet on a reversal of the medium term trend.
Investors should buy the stock at current prices near € 27.2 in order to target the € 29.8.
Rubis : Rubis : A technical turn-around configuration
Summary
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
  • The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.

Strengths
  • Its low valuation, with P/E ratio at 10.5 and 9.63 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
  • The company appears to be poorly valued given its net asset value.
  • The company is one of the best yield companies with high dividend expectations.
  • Sales forecast by analysts have been recently revised upwards.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.

Weaknesses
  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

© MarketScreener.com 2022

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials
Sales 2022 5 874 M 6 197 M 6 197 M
Net income 2022 290 M 306 M 306 M
Net Debt 2022 1 513 M 1 596 M 1 596 M
P/E ratio 2022 9,26x
Yield 2022 7,34%
Capitalization 2 698 M 2 847 M 2 847 M
EV / Sales 2022 0,72x
EV / Sales 2023 0,74x
Nbr of Employees 4 305
Free-Float 84,9%
Upcoming event on RUBIS
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 26,33 €
Average target price 35,04 €
Spread / Average Target 33,1%
EPS Revisions
Managers and Directors
Bruno Krief Chief Financial Officer
Olivier Heckenroth Chairman-Supervisory Board
Chantal Mazzacurati Member-Supervisory Board
Laure Grimonpret-Tahon Member-Supervisory Board
Marie-Hélène Dessailly Member-Supervisory Board